Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
J. Campos.
Enfermedad invasora por Haemophilus influenzae serotipo B.
Med Clin (Barc), 112 (1999), pp. 16-17
[2.]
W.P. Hausdorff, G. Siber, P.R. Paradiso.
Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children.
Lancet, 357 (2001), pp. 950-952
[3.]
A. Domínguez, P. Ciruela, A. Martínez, G. Carmona, N. Torner, N. Cardeñosa, et al.
Epidemiology of invasive pneumococcal disease in infants in Catalonia (Spain).
Abstract book of the 19th annual meeting of the European Society for paediatric infectious diseases, (2001), pp. 109
[4.]
J.D. Wenger, R. Pierce, K. Deaver, R. Franklin, G. Bosley, N. Pigott, et al.
Invasive Haemophilus influenzae disease: a population based evaluation of the role of capsular polysaccharide serotype.
J Infect Dis, 165 (1992), pp. 34-35
[5.]
K.E. Stein.
Thymus independent and thymus dependent responses to polysaccharide antigens.
J Infect Dis, 165 (1992), pp. 49-52
[6.]
A.M. Fry, P. Lurie, M. Gidley, S. Schmink, J. Lingappa, M. Fischer, N. Rosenstein.
Haemophilus influenzae type b disease among amish children in Pennsylvania: reasons for persistent disease.
Pediatrics, 108 (2001), pp. E60
[7.]
J.M. Musser, J.S. Kroll, E.R. Moxon, R.K. Selander.
Clonal population structure of encapsulated Haemophilus influenzae.
Infect Immun, 56 (1988), pp. 1837-1845
[9.]
F. García Martín, J. Ruiz Contreras.
Vacunas neumocócicas: ¿una solución a diferentes problemas?.
An Esp Pediatr, 52 (2000), pp. 207-211
[10.]
S. Black, H. Shinefield, B. Fireman, E. Lewis, P. Ray, J.R. Hansen, and the Northern California Kaiser permanent vaccine study Center Group, et al.
Efficacy, safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in children.
Pediatr Infect Dis J, 19 (2000), pp. 187-195
[11.]
A. Fenoll, I. Jado, D. Vicioso, S. Berrón, J.E. Yuste, J. Casal.
Streptococcus pneumoniae in children in Spain: 1990-1999.
Acta Paediatr, 89 (2000), pp. 44-50
[12.]
M.C.J. Maiden.
Population structure of Neisseria meningitidis.
Emerging strategies in the fight against meningitis: molecular and cellular aspects., pp. 151-169
[13.]
S. Berrón, L. De la Fuente, E. Martín, J.A. Vázquez.
Increasing incidence of meningococcal disease in Spain associated with a new variant of serogroup C.
Eur J Clin Microbiol Infect Dis, 17 (1998), pp. 85-99
[14.]
L. Salleras, A. Domínguez.
Estrategias de vacunación frente al meningococo del serogrupo C en España.
Vacunas, 2 (2001), pp. 10-17
[15.]
M.E. Ramsay, N. Andrews, E.B. Kaczmarski, E. Miller.
Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England.
Lancet, 357 (2000), pp. 195-196
[16.]
R. Borrow, D. Goldblatt, N. Andrews, P. Richmond, J. Southern, E. Miller.
Influence of prior meningococcal C polysaccharide vaccination on the response and generation of memory after meningococcal C conjugate vaccination in young children.
J Infect Dis, 184 (2001), pp. 377-380
[17.]
J.S. Swartley, A.A. Marfin, S. Edupuganti, L.J. Liu, P. Cieslak, B. Perkins, J.D. Wenger, D. Stephens.
Capsule swiching of Neisseria meningitidis.
Proc Natl Acad Sci USA, 94 (1997), pp. 271-276
[18.]
Maiden MCJ, Spratt BG. Meningococcal conjugate vaccines: new opportunities and new challenges. Lancet 354:615-6
[19.]
J. Finne, M. Leinonen, P.H. Makela.
Antigenic similarities between brain components and bacteria causing meningitis: implications for vaccine development and pathogenesis.
Lancet, 2 (1983), pp. 355-357
[20.]
J.T. Poolman, C. Feron, G. Desquene, P.A. Denoël, S. Dessoy, K.K. Goraj, et al.
Outer membrane vesicles and other options for a meningococcal B vaccine.
Emerging strategies in the fight against meningitis: molecular and cellular aspects., pp. 133-149
Copyright © 2003. Elsevier España, S.L.. Todos los derechos reservados
